Ayala Pharmaceuticals, Inc. (AYLA)

NASDAQ: AYLA · IEX Real-Time Price · USD
1.34
-0.02 (-1.47%)
Aug 12, 2022 1:28 PM EDT - Market open

Income Statement (Trailing)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ending 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Revenue
2.993.513.363.43.683.713.083.263.072.33---0
Revenue Growth (YoY)
-18.77%-5.45%9.36%4.11%19.90%58.87%--------
Cost of Revenue
-4.11-3.51-4.05-4.02-3.74-3.713.082.912.021.29---0
Gross Profit
7.17.017.427.427.427.42-00.361.051.05---0
Selling, General & Admin
9.429.289.699.358.367.376.245.324.84.34---3.29
Research & Development
30.5229.9429.227.2624.222.4119.4818.4316.814.42---5.74
Operating Expenses
39.9339.2238.8936.6132.5729.7825.7223.7521.618.76---9.04
Operating Income
-32.83-32.21-31.48-29.19-25.15-22.36-25.72-23.4-20.55-17.71----9.04
Interest Expense / Income
0.260.26-0.06-0.06-0.06-0.060000---0
Other Expense / Income
6.97.017.567.537.477.42-00.01-0.05-0.23000-0.45
Pretax Income
-40-39.48-38.98-36.67-32.56-29.72-25.72-23.4-20.5-17.49000-8.59
Income Tax
0.720.780.630.580.550.430.450.380.350.31---0.29
Net Income
-40.71-40.25-39.6-37.25-33.12-30.15-26.17-23.78-20.85-17.79----8.87
Net Income Common
-40.71-40.25-39.6-37.25-33.12-30.15-26.17-23.78-20.85-17.79----8.87
Shares Outstanding (Basic)
151414141310139555555
Shares Outstanding (Diluted)
15141414131013955----
Shares Change
18.72%46.02%14.36%59.86%157.79%98.02%--------
EPS (Basic)
-2.75-2.80-2.90-2.81-2.80-3.06-3.73-4.15-4.17-3.57----1.80
EPS (Diluted)
-2.75-2.80-2.90-2.81-2.80-3.06-3.73-4.15-4.17-3.57----
Free Cash Flow Per Share
-2.53-2.66-2.59-2.57-2.39-2.80-1.96-2.34-3.79-3.27----1.34
Gross Margin
237.52%200.00%220.45%218.31%201.47%200.00%-0.10%10.94%34.17%44.94%----
Operating Margin
-1098.06%-918.60%-935.70%-859.40%-683.24%-603.05%-836.18%-716.98%-669.38%-758.83%----
Profit Margin
-1361.64%-1148.15%-1177.26%-1096.41%-899.65%-813.00%-850.81%-728.78%-679.19%-762.30%----
Free Cash Flow Margin
-1294.18%-1094.15%-1115.13%-1090.58%-837.38%-743.96%-808.42%-647.13%-616.38%-697.51%----
Effective Tax Rate
-1.79%-1.97%-1.61%-1.57%-1.70%-1.43%-1.77%-1.62%-1.72%-1.75%----3.33%
EBITDA
-39.7-39.05-38.85-36.54-32.33-29.6-25.48-23.19-20.32-17.34----8.54
EBITDA Margin
-1327.83%-1113.81%-1154.82%-1075.63%-878.21%-798.14%-828.22%-710.73%-661.76%-742.76%----
Depreciation & Amortization
0.030.170.180.190.290.180.240.210.180.15---0.05
EBIT
-39.74-39.22-39.03-36.73-32.62-29.78-25.72-23.4-20.5-17.49----8.59
EBIT Margin
-1328.96%-1118.60%-1160.29%-1081.13%-886.17%-803.05%-836.05%-717.19%-667.72%-749.19%----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).